The LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induces fibrosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS ONE 8 (2013) 11, e81356
- Schlagwort
-
Atemwegskrankheit
Atemnot
- Ereignis
-
Veröffentlichung
- (wo)
-
Münster
- (wer)
-
Universitäts- und Landesbibliothek Münster
- (wann)
-
2013
- Urheber
-
Alnajar, Abdulaleem
Nordhoff, Carolin
Schied, Tanja
Chiquet-Ehrismann, Ruth
Loser, Karin
Vogl, Thomas
Ludwig, Stephan
Wixler, Viktor
- URN
-
urn:nbn:de:hbz:6-44319594399
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:50 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Alnajar, Abdulaleem
- Nordhoff, Carolin
- Schied, Tanja
- Chiquet-Ehrismann, Ruth
- Loser, Karin
- Vogl, Thomas
- Ludwig, Stephan
- Wixler, Viktor
- Universitäts- und Landesbibliothek Münster
Entstanden
- 2013
Ähnliche Objekte (12)
The role of the Four and a half LIM only protein 2 (FHL2) in bleomycin induced lung fibrosis
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation
Lung surfactant as pirfenidone vehicle for the treatment of bleomycin induced pulmonary fibrosis
Diminished PLK2 induces cardiac fibrosis and promotes atrial fibrillation
Bleomycin (Mack)
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin]
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin] und Therapieexperimente mit Bleomycin im Meerschweintumormodell
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
The role of the Four and a half LIM only protein 2 (FHL2) in bleomycin induced lung fibrosis
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation
Lung surfactant as pirfenidone vehicle for the treatment of bleomycin induced pulmonary fibrosis
Diminished PLK2 induces cardiac fibrosis and promotes atrial fibrillation
Bleomycin (Mack)
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin]
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin] und Therapieexperimente mit Bleomycin im Meerschweintumormodell
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
The role of the Four and a half LIM only protein 2 (FHL2) in bleomycin induced lung fibrosis
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation
Lung surfactant as pirfenidone vehicle for the treatment of bleomycin induced pulmonary fibrosis
Diminished PLK2 induces cardiac fibrosis and promotes atrial fibrillation
Bleomycin (Mack)
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin]
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin] und Therapieexperimente mit Bleomycin im Meerschweintumormodell